Loading…
avatar for Moheb Nasr

Moheb Nasr

GlaxoSmithKline
Vice President, CMC Regulatory Strategy
Dr. Nasr is responsible for the development and the execution of CMC regulatory strategy at GSK. Prior to joining GSK, he spent over 22 yrs at FDA and established and led the Office of New Drug Quality Assessment (ONDQA). Dr. Nasr was instrumental in the development of QbD concept and several ICH guidelines and continues to play a leading role in global regulatory harmonization. Dr. Nasr is currently the rapporteur of ICH Q12

My Speakers Sessions

Wednesday, June 21
 

2:00pm